Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies

for
Lung Cancer, Bilateral Cancer, Lung Transplant
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 70+

Code: NCT05671887

Recruiting

A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation

for
Advanced Solid Tumor
Location: Houston TX
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.

Sex: All

Age: 18+

Code: NCT05119933

Phase 1, Phase 2, Recruiting

A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer

for
Metastatic Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06693687

Recruiting

ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)

for
Estrogen Receptor-Positive, HER2-Negative,
Location: Seattle WA
Sponsor: EnhancedBio USA Inc.

Sex: All

Age: 18+

Code: NCT04669587

Phase 1, Phase 2, Recruiting

Writing Intervention With Adolescents and Young Adults With Cancer

for
Cancer Patients, Communication Research
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 15 - 25

Code: NCT05975333

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

for
Lung Cancer, Breast Cancer
Location: Hackensack NJ, Montreal, Ottawa, Miami FL, Cleveland OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06618287

Phase 1, Phase 2, Recruiting

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

for
Advanced Cancer, Metastatic Cancer
Location: Durham NC, Miami FL
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06174987

Phase 3, Recruiting

Anti-GD2 ADC M3554 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, Houston TX
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT06641908

Phase 1, Recruiting

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

for
Oligometastatic Breast Carcinoma, Breast Cancer,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05534438

Phase 2, Recruiting

Myeloproliferative Neoplasms (MPNs) Patient Registry

for
Primary Myelofibrosis, Polycythemia Vera,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 0+

Code: NCT02760238

Recruiting

Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

for
Metastatic Malignant Neoplasm in the Brain,
Location: Philadelphia PA
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT03184038

Recruiting

Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer

for
Breast Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Female

Age: 21+

Code: NCT04913064

Recruiting

AIMS Cancer Outcomes Study

for
Neoplasms, Neoplasm Malignant, Advanced Cancer,
Location: Seattle WA
Sponsor: Advanced Integrative Medical Science Institute

Sex: All

Age: 0+

Code: NCT04495790

Recruiting

CTNNA1 Familial Expansion Study

for
Cancer Gene Mutation, Gastric Cancer, Breast Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT05126290

Recruiting

Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing

for
Malignant Neoplasm
Location: Albuquerque NM
Sponsor: New Mexico Cancer Research Alliance

Sex: All

Age: 18+

Code: NCT06207864

Recruiting

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

for
Malignant Neoplasms, Hereditary Neoplastic Syndromes,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2+

Code: NCT00026884

Recruiting

Global Cardio Oncology Registry

for
Breast Cancer, Hematologic Malignancy,
Location: Weston FL
Sponsor: The Cleveland Clinic

Sex: All

Age: 18+

Code: NCT05598879

Recruiting

BostonGene and Exigent Genomic INsight Study

for
Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma
Location: Rogers AR, Houston TX, Tulsa OK, Albuquerque NM,
Sponsor: BostonGene

Sex: All

Age: 18+

Code: NCT06272864

Recruiting

The Intersection of Oncology Care and Worker Well-Being

for
Solid Tumor
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: Male

Age: 21 - 70

Code: NCT05250284

Recruiting

Scalp Cooling in MBC

for
Metastatic Breast Cancer, Chemotherapy-induced Alopecia
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04986579

Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial